Far East Bio Tec Co (ROCO:6886) Debt-to-Equity : 0.15 (As of Jun. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Far East Bio Tec Co Debt-to-Equity?

Far East Bio Tec Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2024 was NT$19.3 Mil. Far East Bio Tec Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2024 was NT$54.1 Mil. Far East Bio Tec Co's Total Stockholders Equity for the quarter that ended in Jun. 2024 was NT$482.3 Mil. Far East Bio Tec Co's debt to equity for the quarter that ended in Jun. 2024 was 0.15.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Far East Bio Tec Co's Debt-to-Equity or its related term are showing as below:

ROCO:6886' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.08 Med: 0.12 Max: 0.15
Current: 0.15

During the past 4 years, the highest Debt-to-Equity Ratio of Far East Bio Tec Co was 0.15. The lowest was 0.08. And the median was 0.12.

ROCO:6886's Debt-to-Equity is ranked better than
72.5% of 1673 companies
in the Consumer Packaged Goods industry
Industry Median: 0.39 vs ROCO:6886: 0.15

Far East Bio Tec Co Debt-to-Equity Historical Data

The historical data trend for Far East Bio Tec Co's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Far East Bio Tec Co Debt-to-Equity Chart

Far East Bio Tec Co Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

0.13

0.11

0.08

Far East Bio Tec Co Semi-Annual Data
	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Debt-to-Equity	Get a 7-Day Free Trial			0.12	0.11	0.09	0.08	0.15

Competitive Comparison of Far East Bio Tec Co's Debt-to-Equity

For the Packaged Foods subindustry, Far East Bio Tec Co's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Far East Bio Tec Co's Debt-to-Equity Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Far East Bio Tec Co's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Far East Bio Tec Co's Debt-to-Equity falls into.

Far East Bio Tec Co Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Far East Bio Tec Co's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(15.977	+	21.673)	/	488.625
	=	0.08

Far East Bio Tec Co's Debt to Equity Ratio for the quarter that ended in Jun. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(19.316	+	54.087)	/	482.299
	=	0.15

Far East Bio Tec Co (ROCO:6886) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Far East Bio Tec Co Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Far East Bio Tec Co's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Far East Bio Tec Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Far East Bio Tec Co Ltd (ROCO:6886) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.3. Yuan Chui Street, Room A, 13th Floor, Nan-Gang District, Taipei, TWN, 115

Website

https://www.febico.com.tw

Far East Bio Tec Co Ltd is a manufacturer of Organic Spirulina, Organic Chlorella, Spirulina natural, and Chlorella natural, nutritional supplements. The firm uses fermentation facilities to produce high-quality nattokinase and spore-forming probiotics. Its products comprise products Organic Spirulina, Organic Chlorella, Chlorella Growth Factor, Phycocyanin, Nattokinase, Lactobacillus sporogenes probiotics, Apogen Microalgae Protein, DHA Algae Oil.

Far East Bio Tec Co Headlines

No Headlines